Market Cap 127.16M
Revenue (ttm) 590,000.00
Net Income (ttm) -45.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,771.19%
Debt to Equity Ratio 0.00
Volume 352,600
Avg Vol 1,208,958
Day's Range N/A - N/A
Shares Out 68.37M
Stochastic %K 26%
Beta 1.32
Analysts Strong Sell
Price Target $8.36

Company Profile

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative brea...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 952 7570
Address:
11055 Flintkote Avenue, San Diego, United States
jrh34
jrh34 Mar. 15 at 3:29 AM
$CRDF Cup and Handle forming.
1 · Reply
Blakeruss1
Blakeruss1 Mar. 14 at 1:15 AM
$CRDF I’m hearing big news next week!!!
1 · Reply
jrh34
jrh34 Mar. 13 at 11:19 PM
$CRDF sudden interest in a biotechs patent typically happens when parties behind the scenes realize that IP suddenly has value and are seeking leverage. No one pays attention to worthless patents.
3 · Reply
Indo
Indo Mar. 13 at 8:46 PM
$CRDF Article on Pfizer ignite no more https://www.fiercebiotech.com/biotech/pfizer-ignite-designed-accelerate-promising-biotech-therapies-fizzles-out?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech+Tracker&oly_enc_id=2104I6474078C5G
0 · Reply
Blakeruss1
Blakeruss1 Mar. 13 at 7:17 PM
$CRDF next week we crush !!!
0 · Reply
Teskonik
Teskonik Mar. 13 at 6:38 PM
$CRDF sleepy market waiting for iran news. If hormus vessel traffic not goes on next week....#.
0 · Reply
frogman2000
frogman2000 Mar. 13 at 6:18 PM
$CRDF no buyers coming out of two conferences this week tells me the meetings were super secret and had selected.
2 · Reply
PSDL75
PSDL75 Mar. 13 at 6:04 PM
$CRDF slowly bleeding these out $TMC $MGNX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 5:40 PM
$CRDF RSI: 63.68, MACD: -0.0117 Vol: 0.17, MA20: 1.82, MA50: 2.14 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
McGinvests
McGinvests Mar. 13 at 5:01 PM
$CRDF 💩 please just spike a bit so I can get out.
0 · Reply
Latest News on CRDF
Cardiff Oncology: Preparing For A Defining 2026

Oct 25, 2025, 7:50 AM EDT - 5 months ago

Cardiff Oncology: Preparing For A Defining 2026


Cardiff Oncology: Data Update Resolves Some Signals

Jul 30, 2025, 11:32 AM EDT - 8 months ago

Cardiff Oncology: Data Update Resolves Some Signals


Cardiff Oncology Names Roger Sidhu as Medical Chief

Jun 17, 2025, 4:39 PM EDT - 9 months ago

Cardiff Oncology Names Roger Sidhu as Medical Chief


Cardiff Oncology: Buying The First-Line Onvansertib Strategy

May 14, 2025, 9:05 AM EDT - 10 months ago

Cardiff Oncology: Buying The First-Line Onvansertib Strategy


Cardiff Oncology: Expecting Massive Updates In Colon Cancer Soon

May 2, 2025, 3:35 AM EDT - 11 months ago

Cardiff Oncology: Expecting Massive Updates In Colon Cancer Soon


Cardiff Oncology to Present at Upcoming Investor Conferences

Feb 24, 2025, 4:05 PM EST - 1 year ago

Cardiff Oncology to Present at Upcoming Investor Conferences


Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:18 AM EDT - 1 year ago

Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript


jrh34
jrh34 Mar. 15 at 3:29 AM
$CRDF Cup and Handle forming.
1 · Reply
Blakeruss1
Blakeruss1 Mar. 14 at 1:15 AM
$CRDF I’m hearing big news next week!!!
1 · Reply
jrh34
jrh34 Mar. 13 at 11:19 PM
$CRDF sudden interest in a biotechs patent typically happens when parties behind the scenes realize that IP suddenly has value and are seeking leverage. No one pays attention to worthless patents.
3 · Reply
Indo
Indo Mar. 13 at 8:46 PM
$CRDF Article on Pfizer ignite no more https://www.fiercebiotech.com/biotech/pfizer-ignite-designed-accelerate-promising-biotech-therapies-fizzles-out?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech+Tracker&oly_enc_id=2104I6474078C5G
0 · Reply
Blakeruss1
Blakeruss1 Mar. 13 at 7:17 PM
$CRDF next week we crush !!!
0 · Reply
Teskonik
Teskonik Mar. 13 at 6:38 PM
$CRDF sleepy market waiting for iran news. If hormus vessel traffic not goes on next week....#.
0 · Reply
frogman2000
frogman2000 Mar. 13 at 6:18 PM
$CRDF no buyers coming out of two conferences this week tells me the meetings were super secret and had selected.
2 · Reply
PSDL75
PSDL75 Mar. 13 at 6:04 PM
$CRDF slowly bleeding these out $TMC $MGNX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 5:40 PM
$CRDF RSI: 63.68, MACD: -0.0117 Vol: 0.17, MA20: 1.82, MA50: 2.14 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
McGinvests
McGinvests Mar. 13 at 5:01 PM
$CRDF 💩 please just spike a bit so I can get out.
0 · Reply
Cutlass
Cutlass Mar. 13 at 4:09 PM
$CRDF 💤💤💤
2 · Reply
Blakeruss1
Blakeruss1 Mar. 13 at 3:20 PM
$CRDF ripping higher !!
0 · Reply
Blakeruss1
Blakeruss1 Mar. 13 at 2:52 PM
$CRDF red to green scenario unfolding
0 · Reply
nowandagain
nowandagain Mar. 13 at 2:48 PM
$CRDF Get a new line. Better yet, do us all a favor and get off ST. Nobody wants to scroll through your endless stupid one liners.
3 · Reply
JN75
JN75 Mar. 13 at 2:45 PM
0 · Reply
Blakeruss1
Blakeruss1 Mar. 13 at 2:23 PM
$CRDF about to go parabolic
0 · Reply
Blakeruss1
Blakeruss1 Mar. 13 at 1:37 PM
$CRDF volume looks good. Need price to follow
0 · Reply
Blakeruss1
Blakeruss1 Mar. 13 at 12:58 PM
$CRDF up big pre market. Today could be epic
0 · Reply
frogman2000
frogman2000 Mar. 13 at 12:59 AM
$CRDF bring forward @Indo yep, know it very well. Doesn’t change my earlier comment. My comment based the exact verbiage. They have 3 options The language creates a window of time that when you add in all the other factors…. PFE agreement and access to data Quick Data release Leadership removal No immediate push to replace leadership VP clinical removal Notice of breach date/notification date Oppenheimer TD Cowan Barclay (not just a convention but arranged meetings with prospects) Leerink (not just a convention but arranged meetings with prospects) Fact that Nerv will never have a better opportunity to renegotiate terms, I.e, before a acquisition …. An acquisition is underway and the dispute has provided us with a very real timeline and window into what will happen next.
0 · Reply
BullRun4
BullRun4 Mar. 13 at 12:52 AM
$CRDF Wow, this chat room has been super quiet lately. Well may be not that quiet as I have blocked about 15-18 short clowns in the last 12 months. It has been very quiet lately but for good reasons as meetings in secrecy are probably taking place. At this point in time waiting is the name of the game and the longer it is before Cardiff reports mature PFS and DOR the better it will be. I guess that April and May will be much more exciting than March, so hang in there!!
0 · Reply
Blakeruss1
Blakeruss1 Mar. 12 at 7:51 PM
$CRDF held beautifully today
0 · Reply
Messerschmittbf109
Messerschmittbf109 Mar. 12 at 7:19 PM
$CRDF on support … it is time …
0 · Reply